Advertisement

Johnson's

Main information

  • Trade name:
  • Johnson's Flea-Guard Waterproof Flea and Tick 15% w/w Collar for Large Dogs
  • Available from:
  • Virbac S.A.
  • Pharmaceutical form:
  • Collar
  • Prescription type:
  • AVM-GSL - Authorised Veterinary Medicine – General Sales List
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug
Advertisement

Documents

Localization

  • Available in:
  • Johnson's Flea-Guard Waterproof Flea and Tick 15% w/w Collar for Large Dogs
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Dogs
  • Therapeutic area:
  • Ectoparasiticide

Other information

Advertisement

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Authorized
  • Authorization number:
  • 05653/4099
  • Authorization date:
  • 23-01-2000
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Advertisement

Revised: March 2014

AN: 01134/2013

SUMMARY OF THE PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Johnson’s Flea-Guard Waterproof Flea and Tick 15% w/w Collar for

Large Dogs

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

Diazinon 15% w/w

Dyes

Black collar: flash black 19976 0.026 % w/w

Brown collar: flash black 19976 0.0087 % w/w

red ferric oxide 0.035 % w/w

Red collar: ariabel scarlet 0.5 % w/w

lithol rubine K4566 0.1 % w/w

Beige collar: flash beige 40232 0.3 % w/w

Green collar: tartrazine lake (E102) 0.28 % w/w

blue alphazurine lake 0.12 % w/w

titanium dioxide 0.1 % w/w

Blue collar: flash blue 47949 0.16 % w/w

Yellow collar: titanium dioxide (E171) 0.12 % w/w

quinoline yellow certolake 0.48 % w/w

flash yellow 47948 0.3 % w/w

White collar: titanium dioxide 0.15 % w/w

Pink collar: titanium dioxide 0.45 % w/w

lithol rubine K4566 0.001 % w/w

On the active strip, a reflective band may be attached.

For a full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Collar.

41 g – 65 cm – coloured plastic strip provided with a buckle.

4. CLINICAL PARTICULARS

4.1. Target species

Dogs.

4.2. Indications for use, specifying the target species

For the control of fleas and ticks on dogs for up to 5 months.

Revised: March 2014

AN: 01134/2013

4.3. Contra-indications

Do not use on puppies under 12 weeks of age.

4.4. Special warnings for each target species

If signs of disease persist or appear, consult your veterinary surgeon.

Fleas from pets often infest the animal’s basket, bedding and regular

resting areas such as carpets and soft furnishings which should be

treated with a suitable insecticide and vacuumed regularly. If you have

several dogs, they must all be treated. Other animals in the same

household should all be treated with an appropriate authorised product.

Ticks will detach from the host within 24-48 hours after infestation

without having had a blood meal, as a rule. An attachment of single ticks

after treatment cannot be excluded. For this reason, a transmission of

infectious disease by ticks cannot be completely excluded if conditions

are unfavourable.

4.5. Special precautions for use

i) Special precautions for use in animals

Do not allow animals to chew the collar.

ii) Special precautions to be taken by the person administering

the veterinary medicinal product to animals

Do not remove collar from pack until ready to use.

DO NOT ALLOW CHILDREN TO PLAY WITH THE COLLAR.

Do not allow children to suck or chew the collar.

Do not smoke, eat or drink while handling collar.

Do not sleep with pets wearing collars.

Dimpylate/Diazinon is an organophosphorus compound: DO

NOT handle if under medical advice not to work with

ANTICHOLINESTERASES.

Avoid excessive handling of the collar.

Cut off any excess collar with scissors and dispose of safely.

If you feel unwell after handling the collar, seek medical

advice.

Wash hands thoroughly after handling the collar.

4.6. Adverse reactions (frequency and seriousness)

Remove the collar immediately should any signs of skin irritation or

adverse reaction occur.

REMOVE THE COLLAR FROM DOG IMMEDIATELY SHOULD ANY

SIGNS OF DROWSINESS, LISTLESSNESS, HYPERSALIVATION,

TREMOR OR RESPIRATORY DIFFICULTIES DEVELOP SOON AFTER

FIXING OF COLLAR.

Revised: March 2014

AN: 01134/2013

4.7. Use during pregnancy, lactation or lay

Not for use on nursing or lactating bitches.

Remove fleas from young puppies and nursing bitches by careful use of

a flea comb.

4.8. Interaction with other medicinal products and other forms of

interaction

Do not use any other insecticides while the collar is being worn or within

7 days of removal.

4.9. Amounts to be administered and administration route

Insecticidal collar weighing 41 g and 65 cm in length, for use on large

dogs.

For external use only.

Remove the collar from blister and fasten around the dog’s neck. When

fitted to the growing dog, ensure the collar is loosened as the animal

grows. In the fully-grown dog, a correct fitting will allow two fingers to be

inserted between the collar and the neck. Any excess length of collar

extending beyond the buckle should be cut off with scissors and

disposed of safely with the domestic refuse.

The collar does not need to be removed when the animal is being

bathed as the insecticidal activity remains unaffected by water. Leave in

place until the collar effective life is exhausted. Replace after 5 months if

reinfestation with fleas or ticks is a risk.

4.10. Overdose (symptoms, emergency procedures, antidotes), if

necessary

Diazinon is an organophosphorus insecticide and atropine is antidotal.

Remove the collar immediately if any signs of skin irritation or adverse

reactions occur. Signs of overdosage include drowsiness, listlessness,

hypersalivation, tremor or respiratory difficulties.

4.11. Withdrawal period

Not applicable.

5. PHARMACOLOGICAL PROPERTIES

Therapeutic group: ectoparasiticides for topical use, organophosphorus

compounds.

ATCvet code: QP53AF03.

The product contains diazinon as a parasiticide.

Revised: March 2014

AN: 01134/2013

5.1. Pharmacodynamic properties

Diazinon, an organophosphorus parasiticide, is active against common

fleas (Ctenocephalides) and ticks (Rhipicephalus or Dermacentor) of

dogs. It acts mainly by inhibiting insect enzymes such as

cholinesterases. This is achieved when diazinon competes with

acetylcholine, responsible for nerve impulses, by binding to the esterase

site of the cholinesterase molecules.

Acetylcholine, degraded at a lower pace, accumulates and induces

disorders. Because the metabolism of diazinon in insects is very slow,

irreversible poisoning is achieved.

5.2. Pharmacokinetic particulars

In mammals, cholinesterase activity similarly decreases. However, this is

only transitory since enzyme synthesis is resumed and diazinon is

degraded within a very-short period of time.

Diazinon being slowly released from the collar matrix, the product

remains active for up to 5 months.

6. PHARMACEUTICAL PARTICULARS

6.1. List of excipients

Dyes

Black collar: - flash black 19976

Brown collar: - flash black 19976

- red ferric oxide

Red collar: - ariabel scarlet

- lithol rubine K4566

Beige collar: - flash beige 40232

Green collar: - tartrazine lake (E102)

- blue alphazurine lake

- titanium dioxide

Blue collar: - flash blue 47949

Yellow collar: - titanium dioxide (E171)

- quinoline yellow certolake

- flash yellow 47948

White collar: - titanium dioxide

Pink collar: - titanium dioxide

- lithol rubine K4566

- Dibutyl phthalate

- Soya-bean oil

- Calcium stearate

- Polyvinyl chloride

6.2. Incompatibilities

None known.

Revised: March 2014

AN: 01134/2013

6.3. Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2

years.

6.4. Special precautions for storage

Do not remove the collar from the pack until ready to use.

Do not store above 25 °C.

Protect from direct sunlight.

6.5. Nature and composition of immediate packaging

Blister pack of one 41-g impregnated-PVC collar: pocket and lid in

acrylonitrile/methyl acrylate/butadiene co-polymer on backing card, heat

sealed.

6.6. Special precautions for the disposal of unused veterinary medicinal

product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived

from such veterinary medicinal products should be disposed of in

accordance with local requirements.

EXTREMELY DANGEROUS to fish and aquatic life. Do not contaminate

ponds, waterways or ditches with the collar or empty packaging.

7. MARKETING-AUTHORISATION HOLDER

Virbac S.A.

1ère Avenue

2065m – L.I.D.

06516 Carros Cedex

France

8. MARKETING-AUTHORISATION NUMBER

Vm

05653/4099

9. DATE OF FIRST AUTHORISATION

Date: 23 January 2000

10. DATE OF REVISION OF THE TEXT

Date: March 2014

24 March 2014

18-1-2017



DHPC – Xarelto® (Rivaroxaban)

DHPC – Xarelto® (Rivaroxaban)

Risiko von Stevens-Johnson-Syndrom und von Agranulozytose

Swissmedic - Swiss Agency for Therapeutic Products

29-12-2016

WOMENS ROGAINE UNSCENTED (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

WOMENS ROGAINE UNSCENTED (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

Updated Date: Dec 29, 2016 EST

US - DailyMed

29-12-2016

WOMENS ROGAINE - UNSCENTED (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

WOMENS ROGAINE - UNSCENTED (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

Updated Date: Dec 29, 2016 EST

US - DailyMed

29-12-2016

MENS ROGAINE EXTRA STRENGTH (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

MENS ROGAINE EXTRA STRENGTH (Minoxidil) Solution [Johnson Johnson Consumer Inc.]

Updated Date: Dec 29, 2016 EST

US - DailyMed

12-12-2016

AVEENO BABY DAILY MOISTURE (Dimethicone) Lotion [Johnson Johnson Consumer Inc.]

AVEENO BABY DAILY MOISTURE (Dimethicone) Lotion [Johnson Johnson Consumer Inc.]

Updated Date: Dec 12, 2016 EST

US - DailyMed

Advertisement